GEORGE B ABERCROMBIE
CIK 1485939 · CHIEF EXECUTIVE OFFICER · last filed 2024-06-14
GEORGE B ABERCROMBIE is a CHIEF EXECUTIVE OFFICER who has filed 47 SEC Form 4 insider transactions across 7 companies since 2010. The most recent filing, for BCRX, was dated Jun 14, 2024. Across all open-market trades the lifetime net is −$2.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $7.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$6.99M
7
47
-$2.07M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BCRX | Director | 36,431 | $8.70 | $316.9K | -$1.64M | 23 | 2024-06-14 |
| Fresh Tracks Therapeutics, Inc. (BBI) Delisted | CHIEF EXECUTIVE OFFICER | 19,312 | $2.35 | $45.4K | $0 | 1 | 2020-02-19 |
| INVA | Sr. VP & Chief Comm. Officer | 293,479 | $22.74 | $6.67M | -$429.3K | 14 | 2018-08-22 |
| Innoviva, Inc. (THRX) Delisted | Sr. VP, Corp. Partnerships | 81,429 | $4.06 | $330.6K | $0 | 1 | 2015-01-09 |
| Ocera Therapeutics, Inc. (TZYM) Delisted | Director | — | — | — | $0 | 3 | 2012-08-09 |
| INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | Director | 0 | — | — | $0 | 4 | 2011-05-16 |
| Alaunos Therapeutics, Inc. (ZIOP) Delisted | Director | 25,000 | $0.87 | $21.6K | $0 | 1 | 2010-04-06 |
Recent Filings
47 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-14 | BCRX | Grant (A) | +6,820 | $0 | EDGAR |
| 2023-06-15 | BCRX | Grant (A) | +16,745 | $0 | EDGAR |
| 2022-06-09 | BCRX | Grant (A) | +12,866 | $0 | EDGAR |
| 2022-04-20 | BCRX | Mixed | — | -$38.6K | EDGAR |
| 2022-02-16 | BCRX | Mixed | — | -$75.9K | EDGAR |
| 2021-11-17 | BCRX | Mixed | — | -$44.8K | EDGAR |
| 2021-09-17 | BCRX | Mixed | — | -$62.1K | EDGAR |
| 2021-09-14 | BCRX | Mixed | −3,000 | -$914.0K | EDGAR |
| 2021-07-19 | BCRX | Mixed | — | -$65.3K | EDGAR |
| 2021-05-27 | BCRX | Grant (A) | — | $0 | EDGAR |